Fractionated breath condensate sampling: H2O2 concentrations of the alveolar fraction may be related to asthma control in children by Trischler, Jordis et al.
RESEARCH Open Access
Fractionated breath condensate sampling: H2O2
concentrations of the alveolar fraction may be
related to asthma control in children
Jordis Trischler
1, Nick Merkel
1, Stephanie Könitzer
2, Christina-Maria Müller
1, Susanne Unverzagt
3 and
Christiane Lex
1*
Abstract
Background: Asthma is a chronic inflammatory disease of the airways but recent studies have shown that alveoli
are also subject to pathophysiological changes. This study was undertaken to compare hydrogen peroxide (H2O2)
concentrations in different parts of the lung using a new technique of fractioned breath condensate sampling.
Methods: In 52 children (9-17 years, 32 asthmatic patients, 20 controls) measurements of exhaled nitric oxide
(FENO), lung function, H2O2 in exhaled breath condensate (EBC) and the asthma control test (ACT) were performed.
Exhaled breath condensate was collected in two different fractions, representing mainly either the airways or the
alveoli. H2O2 was analysed in the airway and alveolar fractions and compared to clinical parameters.
Results: The exhaled H2O2 concentration was significantly higher in the airway fraction than in the alveolar fraction
comparing each single pair (p = 0.003, 0.032 and 0.040 for the whole study group, the asthmatic group and the
control group, respectively). Asthma control, measured by the asthma control test (ACT), correlated significantly
with the H2O2 concentrations in the alveolar fraction (r = 0.606, p = 0.004) but not with those in the airway
fraction in the group of children above 12 years. FENO values and lung function parameters did not correlate to the
H2O2 concentrations of each fraction.
Conclusion: The new technique of fractionated H2O2 measurement may differentiate H2O2 concentrations in
different parts of the lung in asthmatic and control children. H2O2 concentrations of the alveolar fraction may be
related to the asthma control test in children.
Keywords: Paediatric asthma, exhaled airway markers, oxidative stress
Background
Asthma is a chronic inflammatory disease that is predomi-
nantly characterised by inflammatory processes of the air-
ways. However, studies have shown that alveoli are also
subject to pathophysiological changes and might play a
central role for asthma control and severity of the disease
[1-4]. In childhood, inflammation is mostly caused by
allergic and eosinophilic changes [5], and so far, alveolar
involvement has been demonstrated mainly by measure-
ment of alveolar nitric oxide, a marker of eosinophilic
inflammation. However, reactive oxygen species (ROS)
like hydrogen peroxide (H2O2) seem to play a role in the
pathophysiology of childhood asthma [6-8]. Jöbsis et al.
demonstrated that in children with asthma, overall exhaled
H2O2 is elevated compared to controls, but to date there is
no account of the contribution of the alveoli to these
elevated H2O2 concentrations [9].
Exhaled breath condensate (EBC) is a well-known
method to collect inflammation mediators and other
soluble particles in exhaled breath [10]. Until recently it
has only been possible to detect markers like H2O2 in
unfractionated breath condensate, which did not allow
detecting the origin of production. A new method of
fractionated sampling now provides the ability to collect
condensate from different parts of the lung. By measur-
ing ROS like H2O2, it may be possible to locate the origin
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any medium, provided the original work is properly cited.of active inflammation and therefore weigh the contribu-
tion of the alveoli to the severity of asthma and asthma
control. Whereas results for fractionated H2O2 measure-
ments in adults with COPD are published, use of this
technique in asthma and in children has not yet been
described [11].
One of the aims of this study was to apply the new
technique of fractionated breath condensate sampling in
children. Through the new technique, the principal aim
was to compare H2O2 in different condensate fractions
in asthma. Our primary hypothesis was that airway
H2O2 concentrations are significantly higher than alveo-
lar concentrations. In addition we aimed to correlate
these results with data of exhaled nitric oxide (FENO),
lung function measurements and the asthma control
test (ACT).
Methods
Subjects
Asthmatic patients (aged 9-17 years) were recruited from
t h ea s t h m ac l i n i co ft h eC h i l d r e n ’sU n i v e r s i t yH o s p i t a l
Halle. Asthma was diagnosed clinically when children
had episodic cough, breathlessness and wheeze respon-
sive to bronchodilators according to International and
American Thoracic Society (ATS) criteria.
Healthy non-atopic controls with no history of chronic
cough, wheezing or other pulmonary symptoms and
without any chronic disease involving the immune sys-
tem (e.g. Crohn’s disease, Diabetes and rheumatic dis-
eases) were recruited in various outpatient clinics.
Subjects who were active smoking or had an acute
respiratory infection during the previous two weeks
were excluded.
Study design
First, subjects underwent clinical examination, an
asthma questionnaire was filled out and atopic sensibili-
sation was tested. Atopic sensibilisation was diagnosed
by RAST or prick test, atopy was defined by a serum-
specific IgE > 0.34 kU/L or a positive skin prick test
(wheal > 2 mm larger than negative control) to at least
one antigen (D. pteronyssinus, D. farinae, cat, dog, grass
pollen, birch pollen, Aspergillus fumigatus). Afterwards
subjects completed FENO measurement, lung function
testing, and collection of fractionated EBC in this chron-
ological order. Subjects completed the study protocol
within 4 hours.
This cross-sectional study was approved by the local
ethics committee of the Martin-Luther-University Halle-
Wittenberg. Written consent was obtained from the
participant’s parents and age-appropriate consent from the
children themselves.
Power analysis: We assumed a probability of 70%
achieving higher values of airway concentrations
compared to alveolar concentrations as clinical relevant.
With this probability and a significant level of a =0 . 0 5
a sample size of 44 subjects is sufficient to achieve a
power of 90% in a two-sided Wilcoxon signed-rank test.
Asthma questionnaire
To evaluate disease control for children 12 years or
older the Asthma Control Test (ACT) was used, for
children younger than 12 years the Childhood Asthma
Control Test was used [12,13]. Due to different scoring
systems, these tests were not comparable. Parents and
subjects were asked for passive smoking histories.
Lung function tests
Bodyplethysmography and spirometry (Masterlab, Jaeger,
Würzburg, Germany) were performed for measurement
of FEV1 (forced expiratory volume in 1 second), VC (vital
capacity), MEF25 (maximal expiratory flow at 25% of
VC), MEF50 (maximal expiratory flow at 50% of VC),
MEF75 (maximal expiratory flow at 75% of VC), ITV
(intrathoracic volume), TLC (total lung capacity), RV%
TLC (residual volume- total lung capacity ratio) and
sRaw, tot (specific airway resistance) as previously reported
for all subjects [14].
FENO -Measurement
FENO was measured for each subject using NiOX
MINO
® (Aerocrine, Sweden), at a flow rate of 50 mL/s,
according to the manufacturer’s instructions.
Collection of fractionated exhaled breath condensate
Exhaled breath condensate was collected according to
the current ATS/ERS guidelines using ECoScreen 2
®
(Filt GmbH, Germany). This new system, constructed to
collect fractionated breath condensate, passes captured
air through two different chambers depending on the
settings for the single exhaled breath volume and the
threshold between the airway and alveolar fraction. The
collector includes a spirometer for measuring exhaled
volumes and peak flows.
For this study, the separation threshold has been set at
one third of the exhaled breath volume based on the
results of Möller et al. [11] which showed, based on
exhaled CO2 profiles, the starting point of the alveolar pla-
teau is at approximately one third of the exhaled breath
volume. Exhaled breath volume was set to 1200 mL for
subjects ≥ 60 kg, leading to sampling volumes of 400 mL
for fraction 1 and 800 mL for fraction 2. Fraction 1 is
thought to represent the airway fraction and fraction 2 the
alveolar fraction. In children less than 60 kg the exhaled
breath volume was proportionately weight-adjusted, with
60 kg and 1200 mL set as 100%. Subjects wore a nose clip
to allow only orally exhaled breath condensate to be col-
lected. Patients were asked to breathe slowly and regularly
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patterns were enforced by asking patients to breathe out
until they heard a beep from the collecting machine.
The sampling period was ended after the total gas
sampling volume was 300 L or 200 L depending on the
subjects’ tolerance. Sampling times and mean peak flow
values were recorded. Breath condensate volumes for
each fraction were measured and condensate immedi-
ately transferred for further analysis.
Analysis of H2O2 concentrations
For further analysis of H2O2 concentration, ECoCheck
(Filt GmbH, Germany) was used as described by Gerritsen
et al. [15]. With this device, the H2O2 value is obtained by
a specific reaction of the substance with oxidase that is
followed by amperometric detection. Values can be mea-
sured in a range of 15 to 10 000 nmol/L according to the
manufacturer’s instructions.
Data analysis
Data was processed using SPSS (version 12.0). Values
are expressed as median and interquartile range (IQR).
Correlations were measured using the Spearman rank
correlation. Comparisons between groups were made
using the Mann-Whitney-U test. Differences of H2O2
concentration between the fractions were analysed by
the Wilcoxon signed-rank test, comparing each single
related sample pair (paired difference test). Results with
p < 0.05 were considered statistically significant.
Results
Patient characteristics
32 asthmatic and 20 non-asthmatic children were
included in this study. Patient characteristics are shown
in table 1. Approximately half of the asthmatic patients
were prescribed inhaled corticosteroids (ICS) with a
median dosage of 200 μg (IQR 0-400 μg).
Asthmatic patients had significantly higher FENO values
than controls (median 17.0 ppm (8.0-39.3) vs. 9.0 ppm
(7.0-11.0), p = 0.001). There were also significant lower
FENO values in asthmatic patients using ICS than in asth-
matic patients without regular usage of ICS (median (IQR)
12.0 ppb (6.5-21.5 ppb) vs. 28.0 ppb (17.0-44.0 ppb),
p = 0.015).
Exhaled H2O2 concentrations and sampling parameters
14 of 32 asthmatic patients and 10 of 20 control sub-
jects succeeded in collecting breath condensate with 300
litres of total gas volume, 18 of 32 patients and 10 of 20
controls only succeeded in collecting 200 litres. Details
of the sampling times, peak flow values and sampled
condensate volumes are presented in table 2. There was
no significant difference in the alveolar and airway H2O2
concentrations whether the total gas sampling volume
was 200 l or 300 l. Therefore the following statistical
calculations were done for asthmatic patients and con-
trols irrespective of the total gas sampling volumes
achieved.
H2O2 concentrations were below the detection limit
(15 nmol/L) in three samples of fraction 1 (airway frac-
tion) and in one sample of fraction 2 (alveolar fraction).
In these 4 cases we used values of 0 nmol/L for statisti-
cal analysis, but only performed nonparametric tests.
Furthermore H2O2 concentrations could not be
obtained in 2 samples of the airway fraction because
sample analysis curves were not acceptable.
No significant correlation was found between H2O2
concentrations of both fractions and the peak flow
values during sampling breath condensate.
Comparison of H2O2 concentrations between the airway
and the alveolar fraction
Comparing H2O2 concentrations between the two frac-
tions for each related single pair we found that H2O2 con-
centrations were significantly higher in the airway fraction
than in the alveolar fraction. P-values using the Wilcoxon
signed-rank test were 0.003, 0.032 and 0.040 for the whole
study group, the asthmatic group and the control group,
respectively. Medians and IQRs are shown in tables 1
and 2, detailed values of each single patient are shown in
Figure 1. P-values were 0.034 for the subgroup of patients
with a sampling volume of 200 L and 0.053 for patients
with a sampling time of 300 L.
There was no significant difference in H2O2 concen-
trations between asthmatic patients and controls. How-
ever, extremely high values above 1000 nmol/L were
only present in asthmatic patients (n = 6) and not in
controls (Figure 1).
Correlation of exhaled H2O2 concentrations to passive
smoking
There was no significant difference in H2O2 concentra-
tions whether the patients or their parents reported sec-
ond hand smoke exposure.
Correlation of exhaled H2O2 concentrations to asthma
questionnaire
H2O2 concentrations in the alveolar fraction, but not in
the airway fraction, were negatively correlated to the
asthma control test for children 12 years or older (r =
-0.606, p = 0.004, Figure 2). One outlier showed very
high H2O2 concentrations with a perfect ACT score.
There was no correlation with the asthma control test
for younger children.
Furthermore H2O2 concentration of both fractions did
not differ based on prescribed ICS use.
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Asthmatic patients Controls
Total gas sampling volume (L) 200 300 p 200 300 p
n 18 14 10 10
Sampling time (min) 8.6 (6.9-11.7) 12.8 (9.3-16.1) 0.01 9.2 (7.9-10.6) 9.7 (8.1-11.1) ns
Peak flow (L/s) 2.2 (1.5-2.7) 2.0 (1.4-2.2) ns 2.1 (1.8-2.6) 2.0 (1.5-2.4) ns
Condensate volume
airway fraction (μL)
410 (293-625) 825 (450-1050) 0.02 400 (303-540) 600 (488-763) 0.007
Condensate volume
alveolar fraction (μL)
1275 (988-1650) 2000 (1400-2400) 0.07 1200 (925-1838) 2150 (1670-2400) 0.009
H2O2 concentration fraction 1 (nmol/L) 290 (95-515) 310 (160-640) ns 250 (95-545) 320 (155-615) ns
H2O2 concentration fraction 2 (nmol/L) 270 (155-475) 190 (115-405) ns 140 (120-290) 250 (135-450) ns
Values as medians (IQR) or numbers, as appropriate; ns: not significant
Table 1 Patients characteristics
Asthmatic patients Controls p
n 32 20
Age (yr) 12.5 (11.0-15.0) 13.5 (12.0-15.8) ns
Female (n) 11 12 ns
Atopy (n) 30 0
Passive smoking 97 n s
Treatment
ICS (n) 17
Beclomethasone
equivalent dosage (μg) 200 (0-400)
Budesonide (n) 13
Fluticasone (n) 4
Bronchodilator (n) 12
Salbutamol 4
Formeterol 8
Montelukast (n) 3
FEV1 (% pred.) 105 (97-118) 107 (101-116) ns
VC (% pred.) 103 (96-112) 101 (89-99) ns
MEF 25 (% pred.) 104 (83-115) 100 (79-113) ns
MEF 50 (% pred.) 94 (76-126) 104 (84-124) ns
MEF 75 (% pred.) 92 (75-117) 125 (91-158) ns
TLC (% pred.) 98 (85-104) 92 (87-100) ns
ITV (% pred.) 101 (82-113) 101 (86-121) ns
RV/TLC (% pred.) 88 (71-98) 92 (73-99) ns
sRaw, tot (kPa*s) 0.67 (0.50-0.91) 0.50 (0.44-0.63) ns
FENO (ppb)* 17.0 (8.0-39.3) 9.0 (7.0-11.0) 0.001
ACT (points)
< 12 years (n = 11) 25 (22-26)
≥ 12 years (n = 21) 23 (21-25)
H2O2 concentrations airway fraction (nmol/L) 290 (155-505) 310 (115-555) ns
H2O2 concentrations alveolar fraction (nmol/L) 220 (140-460) 180 (120-320) ns
Values as medians (IQR) or numbers, as appropriate; ns: not significant
Trischler et al. Respiratory Research 2012, 13:14
http://respiratory-research.com/content/13/1/14
Page 4 of 8Correlation of exhaled H2O2 concentrations to lung
function parameters
We found no correlation between H2O2 concentrations
and lung function parameters as described above. In
particular, there was no correlation between H2O2 con-
centrations in the alveolar fraction and lung function para-
meters, which suggest an involvement of the distal airways
including MEF75 (% pred.) and RV/TLC (% pred.).
Figure 1 Paired exhaled H202 concentrations (● = airway fraction, ○ = alveolar fraction) of asthmatic children and controls. The exhaled
H2O2 concentration was significantly higher in the airway fraction than in the alveolar fraction comparing each single pair (p = 0.003).
Figure 2 Spearman’s correlation between the asthma control test (ACT) in points and H202 concentrations in the alveolar fraction of
asthmatic children 12 years and older. The asthma control test correlated significantly with the H2O2 concentrations in the alveolar fraction (r
= -0.606, p = 0.004).
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values
There was no positive correlation detected between H2O2
concentrations and FENO values in asthmatic patients,
regardless of which fraction was measured. Furthermore,
in 5 out of 6 patients with very high airway H2O2 concen-
trations (above 1000 nmol/L), low NO values (< 20 ppb)
were measured. Looking at alveolar H2O2 concentrations,
the results were similar; both of the two patients who had
H2O2 values above 1000 nmol/L had low NO values
(< 20 ppb).
Discussion
I nt h i ss t u d yw es h o w e df o rt h ef i r s tt i m eas i g n i f i c a n t
difference between H2O2 concentrations in two different
lung compartments of asthmatic children. The H2O2
concentration in the airway fraction was significantly
higher than in the alveolar fraction. Additionally, we
demonstrated a significant correlation of asthma control
and H2O2 concentrations in the alveolar fraction.
Whereas the role of alveolar NO as a non-invasive mar-
ker of inflammation in asthma has been shown, this study
contributes to the assessment of fractionated H2O2 in
this setting. Whereas results of fractionated H2O2 detec-
tion in COPD are published [11], results in asthma and
in children are still missing. The new technique of frac-
tionated H2O2 measurement allows a differentiation of
H2O2 concentrations in different parts of the lung. Our
findings demonstrate a significantly lower concentration
of H2O2 in the alveolar fraction than in the airway frac-
tion of asthmatic patients. These results are in accor-
dance to those of Möller et al. who found lower H2O2
concentrations in the alveolar fraction of adult COPD
patients [11]. The distribution pattern of H2O2,s h o w i n g
lower values in the alveolar fraction than in the airway
fraction, is consistent with the distribution of other
inflammation markers like NO and IL-4 [3,16].
For children 12 years and older, we showed for the first
time that worse asthma control correlates with higher
H2O2 concentrations in the alveolar fraction. There were
outliers, but the results still show a significant trend
towards higher concentrations in suboptimally controlled
asthma. The relationship between lung inflammation in
general and an increased production of reactive oxygen
species is well known [8,17]. However, our findings sup-
port the assumption that inflammation in the alveoli may
play an important role in asthma control.
Growing evidence shows the importance of distribution
patterns of inflammation rather than total values for a
more complex understanding of asthma. Eosinophils as a
marker for inflammation have been found in all parts of
the airways, but the amount of eosinophils in peripheral
airways seems to correlate with asthma severity [1].
Exhaled NO has been frequently linked to eosinophilic
inflammation, and several studies show that high alveolar
NO values correlate with worse asthma control [3,17].
There have been studies that tried to link elevated
alveolar inflammation to peripheral lung function para-
meters. Van Veen et al. could demonstrate a correlation
between alveolar NO and RV/TLC (% pred.), a marker
for distal air trapping [18]. Also TLC and TGV have been
positively correlated to distal lung inflammation mea-
sured by eosinophilic alveolar inflammation [19]. Corre-
lations of distal inflammation to other lung function
parameters like FEV1 and MEF25-75 a r em o r ec o n f l i c t i n g
[19]. In our study, we could not find a correlation
between the mentioned lung function parameters and
the alveolar fraction of H2O2. However, lung function
parameters in children are mostly within normal values
and do not correlate with asthma severity [20], especially
since we excluded patients with acute infections.
We did not find any significant relation between H2O2
concentrations of the airway fraction and FENO,m a i n l y
representing the NO deriving from the airway fraction
[3]. A similar discordant behavior between FENO and
EBC 8-isoprostane, another marker of airway oxidative
stress [21], has been observed in asthmatic children with
exercise-induced bronchoconstriction [22]. This may be
due to different types of airway inflammation, which are
represented by the two values. As shown by us in a for-
mer study, FENO correlates strongly with the amount of
bronchoalveolar lavage (BAL) eosinophils and is generally
thought of as a marker for eosinophilic inflammation
[23]. Sources of H2O2 are thought to be more diverse
compared to those of FENO, since the producing superox-
ide dismutase can be found in a range of cells, i.e. macro-
phages, alveolar type II cells and the amount of H2O2
might be amplified by neutrophilic and eosinophilic per-
oxidases [24-26]. Since we found a significant correlation
between alveolar H2O2 and asthma control, this implies
the importance of measuring an additional biomarker,
not only representing eosinophilic inflammation but oxi-
dative stress. This assumption is strengthened by our
findings that patients with very high H2O2 concentrations
(above 1000 nmol/L) have mostly low FENO values (< 20
ppb). Different phenotypes of inflammation may be mea-
surable in paediatric asthma, providing additional infor-
mation for assessing asthma control. Studies aiming at
assessing other non-eosinophilic exhaled markers of air-
way inflammation including LTB4 [27] and volatile
organic compounds [28] are required to reinforce the
present data.
In our study there was a significant difference in FENO
values but not in H2O2 concentrations between steroid
naïve asthmatic patients and asthmatic patients taking
ICS, leading to the assumption that FENO values, but not
H2O2 concentrations may be suppressed by corticoster-
oids. This may be in accordance to the fact that Horvath
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mal FENO values in their steroid-treated, unstable asth-
matic group [29]. Unfortunately, to our knowledge no
follow-up studies exist looking at H2O2 concentrations
before and after corticosteroid prescription to support our
findings. Also leukotriene receptor antagonists, which are
widely used for asthma treatment [30], reduce FENO con-
centrations in asthmatic children [31], but their effect on
EBC hydrogen peroxide in asthmatic children is unknown
and should be clarified. Likewise, future studies should
establish whether measurement of hydrogen peroxide in
the alveolar fraction of EBC might be useful for choosing
the best pharmacological strategy in children with mild
asthma [32].
We did not find any correlation between asthma con-
trol and H2O2 concentration in the group of children <
1 2y e a r s .T h i sm a yb ed u et ot h em u c hs m a l l e rg r o u po f
children (n = 11 vs. n = 21). Furthermore, assessment of
asthma control for children < 12 years might be more
d i f f i c u l tc o m p a r e dt oc h i l d r e n≥ 12 years, because the
integration of the parents’ perception might cause a bias.
In this study we were the first to apply the new tech-
nique of fractionated breath condensate sampling to
measure H2O2 concentrations in asthmatics and in chil-
dren. We admit that the sampling technique in this
study differed in between our study group, which might
be a weakness of our study. Finally about half of the
children succeeded in collecting 300 litres of gas
volume, whereas the other half only reached 200 litres.
However, there were no significant differences between
H2O2 concentrations in both collecting groups (table 2).
A very difficult issue in collecting fractionated breath
condensate sampling is the determination of the threshold
between the alveolar and the airway fraction. In our study,
we applied the threshold according to the mean gas sam-
pling volumes of both fractions measured in the study of
Möller et al. [11]. We admit that the one third/two third
ratio we chose represents the volume relations in adult air-
ways and may not be applied to the growing lungs of chil-
dren. However, imaging studies show that the airway
surface length/area ratio was linearly associated to alveolar
surface/volume ratio in CT scans of 50 children from
0-17.2 years of age [33]. In the imaging based study by de
Jong and colleagues, there is no over proportional growth
of the alveolar volume, suggesting that the growth of the
airways and the alveoli is closely linked.
Another problematic issue in separating airway and
alveolar compartments is the possible inhomogeneous
narrowing of the asthmatic airways. This could poten-
tially lower alveolar volume values in children with less
controlled asthma. We admit that the accuracy of the
single test might be limited in our young subjects, since
the threshold was not determined individually for each
patient. Whether a capnograph based method instead of
a volume based method for differentiation between both
compartments may be applied in children and will
reveal different results needs further investigations.
We were unable to include a flow restrictor into the
experimental design of the machine to keep the flow con-
stant during the exhalation. Schleiss et al. found out that
H2O2 concentrations negatively correlated to the expira-
tory flow [34]. Concurrent with this, a recent publication
by Gajdocsi et al. showed that H2O2 concentrations are
lower during increased tidal breathing compared to tidal
breathing [35]. In our study, patients had an increased
tidal volume and therefore an increased flow during the
first part of the exhalation. The measured H2O2 concen-
tration could be falsely decreased since the expiratory
flow was higher during collecting the airway fraction. We
measured the expiratory peak flow in our study, but
could not find any significant correlation of this value to
the H2O2 concentrations of either fraction.
Conclusion
In summary, this study showed for the first time that
H2O2 concentrations in exhaled breath condensate were
significantly higher in the airway fraction than in the
alveolar fraction in asthmatic children and young adoles-
cents. Only the H2O2 concentrations of the alveolar frac-
tion correlated with asthma control in children 12 years
and older suggesting that alveolar H2O2 p l a y sar o l ei n
asthma control. However, whether fractionated exhaled
H2O2 may be used as a non-invasive marker of alveolar
involvement in asthmatics needs to be further investigated.
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